Interferon Tumbles, Oral Agents Gain as Initial MS Treatment

(MedPage Today) -- Prescribing patterns of initial disease-modifying therapies for multiple sclerosis have shifted dramatically since 2001, with oral agents driving down the use of platform injectables 73.8% by 2020. The inflection point occurred...
Source: MedPage Today Neurology - Category: Neurology Source Type: news